Prevalence of Thyroid Function Abnormalities in HIV-infected Patients

NCT03149354 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2018-08-07

No results posted yet for this study

Summary

Review the evolution of thyroid function in HIV-infected patients, with sufficient follow-up.

Conditions

  • Thyroid
  • HIV Infections

Interventions

OTHER

Assay of TSH, FT3 and FT4 by immuno-radiometric method

Assay of TSH, FT3 and FT4 by immuno-radiometric method Determine the current prevalence of hypothyroidism in HIV-infected patients

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • Rachel DESAILLOUD, PhD · CHU AMIENS-PICARDIE

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-19
Primary Completion
2022-12-19
Completion
2022-12-19

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03149354 on ClinicalTrials.gov